One in five patients on Nirmatrelvir–Ritonavir experience virologic rebound, new observational study reveals Post author: Post published:November 16, 2023 Post category:uncategorized The frequency of viral rebound (VR) among acute coronavirus disease 2019 patients. You Might Also Like Electronic nudges boost flu vaccination rates among heart attack survivors November 18, 2024 New AI tool maps millions of CD8+ T cells to advance disease research December 4, 2024 Using advanced AI screening tools to improve early detection of myopic maculopathy October 3, 2024